164 related articles for article (PubMed ID: 7758882)
1. Changes of lipolytic enzymes cluster with insulin resistance syndrome. Botnia Study Group.
Knudsen P; Eriksson J; Lahdenperä S; Kahri J; Groop L; Taskinen MR
Diabetologia; 1995 Mar; 38(3):344-50. PubMed ID: 7758882
[TBL] [Abstract][Full Text] [Related]
2. The effects of gender and type of diabetes on HDL-cholesterol.
Merrin PK; Baynes C; Henderson A; Richmond B; Elkeles R
Diabete Metab; 1994; 20(1):20-4. PubMed ID: 8056130
[TBL] [Abstract][Full Text] [Related]
3. Insulin resistance is independently associated with postprandial alterations of triglyceride-rich lipoproteins in type 2 diabetes mellitus.
Annuzzi G; De Natale C; Iovine C; Patti L; Di Marino L; Coppola S; Del Prato S; Riccardi G; Rivellese AA
Arterioscler Thromb Vasc Biol; 2004 Dec; 24(12):2397-402. PubMed ID: 15458975
[TBL] [Abstract][Full Text] [Related]
4. Relationship between postheparin plasma lipases and high-density lipoprotein cholesterol in different types of diabetes.
Laakso M; Sarlund H; Ehnholm C; Voutilainen E; Aro A; Pyörälä K
Diabetologia; 1987 Sep; 30(9):703-6. PubMed ID: 3428502
[TBL] [Abstract][Full Text] [Related]
5. High-density lipoprotein cholesterol concentrations and postheparin hepatic and lipoprotein lipases in obesity: relationships with plasma insulin levels.
Cominacini L; Garbin U; Davoli A; Campagnola M; De Santis A; Pasini C; Pastorino AM; Bosello O
Ann Nutr Metab; 1993; 37(4):175-84. PubMed ID: 8215234
[TBL] [Abstract][Full Text] [Related]
6. Insulin and sulfonylurea therapy in NIDDM patients. Are the effects on lipoprotein metabolism different even with similar blood glucose control?
Romano G; Patti L; Innelli F; Di Marino L; Annuzzi G; Iavicoli M; Coronel GA; Riccardi G; Rivellese AA
Diabetes; 1997 Oct; 46(10):1601-6. PubMed ID: 9313756
[TBL] [Abstract][Full Text] [Related]
7. Insulin therapy induces antiatherogenic changes of serum lipoproteins in noninsulin-dependent diabetes.
Taskinen MR; Kuusi T; Helve E; Nikkilä EA; Yki-Järvinen H
Arteriosclerosis; 1988; 8(2):168-77. PubMed ID: 3279941
[TBL] [Abstract][Full Text] [Related]
8. Persistent abnormalities in lipoprotein composition in noninsulin-dependent diabetes after intensive insulin therapy.
Bagdade JD; Buchanan WE; Kuusi T; Taskinen MR
Arteriosclerosis; 1990; 10(2):232-9. PubMed ID: 2180397
[TBL] [Abstract][Full Text] [Related]
9. Plasma post-heparin lipase activities in the HERITAGE Family Study: the reproducibility, gender differences, and associations with lipoprotein levels. HEalth, RIsk factors, exercise Training and GEnetics.
Després JP; Gagnon J; Bergeron J; Couillard C; Leon AS; Rao DC; Skinner JS; Wilmore JH; Bouchard C
Clin Biochem; 1999 Apr; 32(3):157-65. PubMed ID: 10383074
[TBL] [Abstract][Full Text] [Related]
10. Relationships between the amount of weight loss and post-heparin lipoprotein lipase activity in patients with type II diabetes.
Kasim SE; Darga LL; Holden JH; Khilnani S; Patton S; Jen KL; Lucas CP
Int J Obes; 1991 Dec; 15(12):833-40. PubMed ID: 1794925
[TBL] [Abstract][Full Text] [Related]
11. Normalization of lipoprotein composition by intraperitoneal insulin in IDDM. Role of increased hepatic lipase activity.
Ruotolo G; Parlavecchia M; Taskinen MR; Galimberti G; Zoppo A; Le NA; Ragogna F; Micossi P; Pozza G
Diabetes Care; 1994 Jan; 17(1):6-12. PubMed ID: 8112191
[TBL] [Abstract][Full Text] [Related]
12. Why do low-fat high-carbohydrate diets accentuate postprandial lipemia in patients with NIDDM?
Chen YD; Coulston AM; Zhou MY; Hollenbeck CB; Reaven GM
Diabetes Care; 1995 Jan; 18(1):10-6. PubMed ID: 7698030
[TBL] [Abstract][Full Text] [Related]
13. Exogenous and endogenous postprandial lipid abnormalities in type 2 diabetic patients with optimal blood glucose control and optimal fasting triglyceride levels.
Rivellese AA; De Natale C; Di Marino L; Patti L; Iovine C; Coppola S; Del Prato S; Riccardi G; Annuzzi G
J Clin Endocrinol Metab; 2004 May; 89(5):2153-9. PubMed ID: 15126535
[TBL] [Abstract][Full Text] [Related]
14. Regulation of low-density lipoprotein particle size distribution in NIDDM and coronary disease: importance of serum triglycerides.
Lahdenperä S; Syvänne M; Kahri J; Taskinen MR
Diabetologia; 1996 Apr; 39(4):453-61. PubMed ID: 8777995
[TBL] [Abstract][Full Text] [Related]
15. Gemfibrozil: effect on serum lipids, lipoproteins, postheparin plasma lipase activities and glucose tolerance in primary hypertriglyceridaemia.
Nikkilä EA; Ylikahri R; Huttunen JK
Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):58-63. PubMed ID: 190608
[TBL] [Abstract][Full Text] [Related]
16. Association of high density lipoprotein cholesterol with plasma lipolytic activity and C-peptide concentration in type 2 diabetes.
Baynes C; Rains SG; Wadsworth J; Wilson GA; Richmond W; Elkeles RS
Diabetes Res; 1991 Feb; 16(2):49-53. PubMed ID: 1817805
[TBL] [Abstract][Full Text] [Related]
17. Effect of gemfibrozil on high density lipoprotein subspecies in non-insulin dependent diabetes mellitus. Relations to lipolytic enzymes and to the cholesteryl ester transfer protein activity.
Kahri J; Vuorinen-Markkola H; Tilly-Kiesi M; Lahdenperä S; Taskinen MR
Atherosclerosis; 1993 Aug; 102(1):79-89. PubMed ID: 8257455
[TBL] [Abstract][Full Text] [Related]
18. Effect of the prostaglandin E1 analog enisoprost on glucose and lipid metabolism in patients with type II diabetes mellitus.
Kasim SE; Moran M; Khilnani S; West MA; Jen KL
Horm Metab Res; 1992 Apr; 24(4):176-80. PubMed ID: 1601393
[TBL] [Abstract][Full Text] [Related]
19. The role of insulin insensitivity and hepatic lipase in the dyslipidaemia of type 2 diabetes.
Baynes C; Henderson AD; Anyaoku V; Richmond W; Hughes CL; Johnston DG; Elkeles RS
Diabet Med; 1991 Jul; 8(6):560-6. PubMed ID: 1832357
[TBL] [Abstract][Full Text] [Related]
20. Serum lipoprotein levels and plasma concentrations of insulin, intact and 32, 33 split proinsulin in normoglycaemic relatives of patients with type 2 diabetes.
Gelding SV; Andres C; Niththyananthan R; Richmond W; Gray IP; Johnston DG
Diabet Med; 1994 Oct; 11(8):748-54. PubMed ID: 7851068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
